Hemillan, Merry Jean D.
HRN: 22-92-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2023
CEFUROXIME 500MG (TAB)
07/02/2023
07/08/2023
PO
500 Mg
BID
S/p Episiorrhaphy
Waiting Final Action
Indication: ProphylaxisEmpiric Then Culture-directed Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes